Skip to main content

Table 2 Antibody information

From: Wnt5a/β-catenin-mediated epithelial-mesenchymal transition: a key driver of subretinal fibrosis in neovascular age-related macular degeneration

Target

Catalogue no

Application

(Conc.)

Vendor

α-SMA

Ab7817

WB (1:2,000);

IF (1: 100)

Abcam

collagen I

Ab34170

WB (1:1,000);

IF (1: 100)

Abcam

Dvl2

3224

WB (1:1,000)

CST

fibronectin

15,613-1-AP

WB (1:500);

IF (1: 100)

Proteintech

GAPDH

10,494-1-AP

WB (1: 5,000)

Proteintech

IB4

I21411/I32450

IF (1:2000)

Invitrogen

lamin B1

AF5161

WB (1:500)

Affinity

Naked1

2262

WB (1:1,000)

CST

Non-phospho (Active) β-Catenin (Ser33/37/Thr41)

8814

WB (1:1,000);

IF (1:800)

CST

ROR1

4102

WB (1:1,000)

CST

RPE65

Ab13826

IF (1: 100)

Abcam

vimentin

10,366-1-AP

IF (1: 100)

Proteintech

Wnt3a

2721

WB (1:1,000)

CST

Wnt5a

2392

WB (1:1,000)

CST

ZO-1

61–7300

WB (1:1,000);

IF (1: 100)

Invitrogen

  1. WB, Western blot; IF, immunofluorescence; CST, Cell Signaling Technology